VivoSim Labs, Inc. (VIVS)

From the record

VivoSim Labs, Inc.'s filings since 2017 show 13 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 8 times, the latest 2026-08-21); an auditor change (8-K item 4.01, 2 times, the latest 2023-09-05); a late-report notice (Form NT 10-K or NT 10-Q, 3 times, the latest 2026-06-29) (its current reports).

From the record

VivoSim Labs, Inc.'s 9 filed years say what it did: revenue went from $5 million in fiscal 2018 to $131 thousand in fiscal 2026, down 35.9% a year; it rose in 1 of 7 years; the deepest fall was 100% from fiscal 2018 to fiscal 2021; net income was positive in 0 of 9 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2026-03-31, VivoSim Labs, Inc.'s shareholders' equity was below zero, so the profit on it is not read, and gross profitability: its products earned about 2 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 115 cents per dollar of assets, and net share issuance: its share count grew 76.8% over the year (the filed statements).

From the record

VivoSim Labs, Inc.'s standing among 102 graded names in its industry family: revenue of $131 thousand in fiscal 2026 ranks in the bottom 9% by size; a net margin of -10567.2% ranks in the bottom 15%; revenue growth of -29.3% a year over the last 3 filed years ranks in the bottom 19% (its annual reports).

From the record

VivoSim Labs, Inc.'s leadership, from its insiders' filings and its current reports: no one files under a chief executive's title, so that part is not read; the 7 officers and directors filing in the last fifteen months have been on the record a median of 6.2 years (top 30%); 6 officer or director changes were reported on Form 8-K since 2023-11-13, against the 7 people in charge now (bottom 21%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

VivoSim Labs, Inc.'s room to grow, from the newest filed statements (fiscal 2026): cash of $5 million against no long-term debt tagged leaves 68% of its assets as net cash, top 22% of its family; cash from operations less capital spending is -8264.9% of revenue (bottom 10%); a gross margin of 100% (top 4%); research spending of 3197.7% of revenue (top 16%) (its annual report).

From the record

VivoSim Labs, Inc.'s growth drivers, from the filed years to fiscal 2026: revenue grew -29.3% a year over the last three filed years against -35.9% over all 9, speeding up (top 18% of its family); the newest year grew -9% (bottom 28%); research spending grew -22.2% a year (bottom 11%) (its annual reports). VivoSim Labs, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

VivoSim Labs, Inc.'s newest year against its own record: revenue of $131 thousand in fiscal 2026 came in 45.8% above the $90 thousand its prior three years' pace pointed to (top 32% of its family); net income of $14 million against a prior three-year average of $11 million (bottom 30%); a net margin of a loss larger than its revenue against losses larger than its revenue before (bottom 8%) (its annual reports).